Sign in

CIK 0001745999 · Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
  1. 8-K Event Results of operations
  2. 4 Open-market sale CEO sold 25,000 shares at an average $70.49 ($1,762,216)
  3. DEFA14A Proxy Proxy Materials
  4. 8-K Event Executive or director change
  5. DEF 14A Proxy Proxy Statement
  6. 4 Other acquisition Chief Executive Officer acquired 97 shares (code L)
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 4 Grant or award CEO acquired 69,375 shares (grant or award)
  9. 4 Option exercise President & CSO acquired 4,030 shares (option exercise)
  10. 4 Grant or award CFO acquired 17,500 shares (grant or award)
  11. 4 Other disposition Director disposed of 400,000 shares (other)
  12. 4 Other disposition Director disposed of 400,000 shares (other)
  13. 4 Other disposition 10% owner disposed of 400,000 shares (other)
  14. 424B5 Offering Prospectus
  15. 8-K Event Other events
  16. 424B7 Offering Prospectus
  17. 424B7 Offering Prospectus
  18. S-3ASR Offering Registration Statement
  19. 4 Other disposition Director disposed of 800,000 shares (other)
  20. 4 Other disposition Director disposed of 800,000 shares (other)

Page 21 of 26 · 514 filings